Alane Izu to Aged
This is a "connection" page, showing publications Alane Izu has written about Aged.
Connection Strength
0,130
-
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021 03 06; 397(10277):881-891.
Score: 0,032
-
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021 01 09; 397(10269):99-111.
Score: 0,032
-
Predicting Prognosis of Patients with Chronic Subdural Hematoma: A New Scoring System. World Neurosurg. 2018 Jan; 109:e707-e714.
Score: 0,026
-
Nationwide and regional incidence of microbiologically confirmed pulmonary tuberculosis in South Africa, 2004-12: a time series analysis. Lancet Infect Dis. 2015 Sep; 15(9):1066-1076.
Score: 0,022
-
An acellular pertussis vaccine in healthy adults: safety and immunogenicity. Pennridge Pediatric Associates. Vaccine. 1999 Aug 06; 17(23-24):2999-3006.
Score: 0,007
-
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. JAMA. 1999 Jul 28; 282(4):331-40.
Score: 0,007
-
Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol. 1993 Feb; 28(2 Pt 1):189-97.
Score: 0,005